Pulse ·

Contact sports and MND: what the evidence says after Nathan Charles

Verdict Maybe — watch this

Elite contact-sport athletes face 4 to 15 times the general population's risk of motor neurone disease (MND), based on studies of NFL players, Scottish rugby union players, and soccer players. Current evidence shows association, not proven causation — the biological mechanism remains under investigation. There is no established MND screening protocol for athletes, and no prevention intervention has yet been identified. Former Wallaby Nathan Charles was diagnosed with MND in September 2026, aged 37, having previously overcome cystic fibrosis to play international rugby.

Nathan Charles defied statistics for most of his adult life. Diagnosed with cystic fibrosis as a child — a condition that carried, for his generation, a median life expectancy in the 30s — he not only reached adulthood but played Test rugby for the Wallabies. That arc made him a public symbol of what determination through a serious chronic illness looks like. The announcement in late September 2026 that he had been diagnosed with motor neurone disease at 37 arrived with the particular weight that comes when someone’s story changes abruptly.

He described the experience as “extremely challenging and overwhelming, and at times quite cruel.” Those words are worth receiving before moving to the science.

The elevated risk in elite contact sport athletes

The question of whether contact sport participation raises MND risk is not new, but it is not resolved either. A piece in The Conversation by Professor Alan Pearce — Director of the Australian Sports Brain Bank — summarised the current evidence clearly. Studies of Scottish rugby union players showed approximately 15 times higher MND diagnosis rates compared to the general population. Former NFL players were found to be 4.5 times more likely to die from MND. Soccer players, with heading-related head impact concerns, showed nearly a two-fold elevated risk.

These are striking figures, even at the lower end of that range. The critical caveat is that they demonstrate association, not causation. It is not proven that head trauma causes MND. It is also not proven that it doesn’t. The mechanism is biologically plausible — repeated sub-concussive head impacts appear to cause cumulative neuroinflammation and patterns of protein aggregation that overlap with what is found in MND and other neurodegenerative conditions — but the pathway from “we observe this in the data” to “we understand the mechanism well enough to intervene” is not yet closed.

Pearce also flags that there is currently no MND-specific research in rugby league or Australian rules football populations, despite both sports carrying significant head impact profiles. That absence is a gap in the evidence, not reassurance.

Both-and: what this does and doesn’t mean for sport

The elevated risk figures in elite athletes do not straightforwardly translate into a recommendation for recreational or junior sport participants. The studies are drawn from people with careers of sustained, high-intensity contact — professional athletes over multi-decade exposure windows. The risk calculation for a child playing weekend sport, or an adult in a social competition, is different.

What the evidence does support, at all levels, is treating head injury as a meaningful clinical event rather than an incidental one. Concussion protocols, adequate recovery times, and cumulative impact reduction are not optional extras — they are the clinical response to a literature that keeps pointing in the same direction, even as the causal picture remains incomplete. The sports that have been slowest to update their head injury management are the ones accumulating the most uncomfortable data.

It is also worth noting that Nathan Charles had cystic fibrosis, a condition characterised by systemic inflammation and significant oxidative stress. Whether his MND risk intersects with CF-related biology is not currently known. His case adds to a still-sparse dataset of individual diagnoses — it does not establish a rule. What it does is put another name and face to a clinical question that deserves research attention.

Jai Arrow, Geoff Ablett, Nathan Charles — the names are accumulating in Australian contact sports in a way that the science is still catching up to.

2 cents

No causal verdict has been handed down, and none will come quickly. What is already established is that elite contact-sport athletes develop MND at rates that are not explained by chance alone.

For anyone navigating this as a parent, a former athlete, or someone sitting with neurological symptoms: the evidence at this point supports being informed, not being frightened. If you are experiencing progressive muscle weakness, fasciculations, unexplained functional decline in a limb — particularly with a significant contact sports history — that conversation with your GP is worth having now rather than later. Most causes of those symptoms are not MND. But the assessment matters.

Verdict: maybe — watch this.


Sources cited

  1. With a former Wallaby’s ‘cruel’ diagnosis, is there a link between contact sports and MND? — The Conversation AU
  2. Wallaby who overcame cystic fibrosis to play rugby diagnosed with MND — ABC News Australia

Frequently asked questions

  • Should my child stop playing contact sports because of the MND risk?

    The current evidence does not support a recommendation to stop contact sports participation on MND risk grounds. The elevated risk figures come from studies of elite athletes with prolonged, high-intensity exposure — not recreational or junior sport. The link between head impacts and MND is biologically plausible but not mechanistically proven. What the evidence does support is taking head injury management seriously at all levels: correct concussion protocols, adequate recovery, and cumulative exposure reduction where possible. The risk-benefit picture for an individual child includes fitness, social development, and physical health gains that are also real.

  • What are the earliest symptoms of MND I should look out for?

    MND typically presents with focal muscle weakness or wasting, often starting in one limb, or with slurred speech and difficulty swallowing in bulbar-onset disease. Muscle twitching (fasciculations), stiffness, unexplained tripping or dropping things are early signs. Average age at diagnosis in Australia is mid-50s to 60s — onset at 37 as in Nathan Charles's case is unusual. If you are noticing progressive weakness in a limb or any of these symptoms, a GP review with neurology referral is the appropriate first step. Most causes of focal weakness are not MND, but that assessment matters.